Navigation Links
Pomegranate Juice May Be The Next Best Thing For People With Heart Disease,,

New study has suggested that polyphenolic antioxidants present in the juice of pomegranate may help in reducing stress and atherogenesis. //

Atherogenesis is the process of plaques etc forming in the inner lining of the arteries that make them hard causing a state of atherosclerosis. This causes disturbed blood flow and may cause serious damage to heart. Perceived stress increases the risk of atherogenesis.

The new study shows that cultured human coronary artery endothelial cells exposed to high stress reacted positively to concentrated pomegranate juice. The juice reduced the activation of redox-sensitive genes in atherosclerosis prone mice. When these mice were orally fed with pomegranate juice, the hypercholesterolemic mice at different stages of the disease showed significant reduction in progress of atherosclerosis.

The study shows that pro-atherogenic effects caused by shear stress can be controlled by chronic use of pomegranate juice. This will in future help a lot of people undergoing treatment of atherosclerosis or something similar.

The study was published in the march 2005 issue of the journal Proceedings of the National Academy of Sciences.

Reference: Proceedings of the National Academy of Sciences, March 2005

'"/>




Page: 1

Related medicine news :

1. Pomegranate juice to check fetal brain injury
2. Pomegranate juice delays prostate cancer
3. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
4. Pomegranates Found To Slow Prostate Cancer Progression
5. Pomegranate Juice Consumption May Improve Myocardial Ischemia
6. Pomegranates In Snack-Sized Bars
7. Pomegranate Juice Remedy for Prostate Cancer
8. Pomegranate juice could kill cancer cells
9. Pomegranate juice may cut atherosclerosis risk in diabetics
10. Science Builds Behind Pomegranate Extracts for Health
11. Juices are Best! but which one?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: